ArticleClinical EEG and neuroscience2026
Effect of Anti-Seizure Medications on Interictal Epileptiform Discharges in Focal Epilepsy.
Article in Clinical EEG and neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The purpose of this study was to assess the change in frequency and distribution of focal interictal epileptiform discharges (IEDs) as measured on scalp EEG after anti-seizure medications (ASMs) were weaned in the epilepsy monitoring unit. We retrospectively reviewed the EEG of patients with focal epilepsy on a single ASM. A two-hour EEG epoch was selected at sleep onset during the first day of admission and defined as the high-ASM epoch. This was compared to a two-hour low-ASM epoch at sleep onset after the ASM was weaned, at least 6 h before or after a seizure. IEDs were manually counted and characterized. A total of 115 patients were included. For those on levetiracetam, there was a significant increase in IED quantity when comparing the high-ASM to the low-ASM epoch (mean 40.6 to 71.4, p < 0.001). For those on sodium channel blockers, there was a non-significant trend towards a decrease in IED quantity as the ASM dose was decreased (p = 0.065). There was no statistically significant change found for other individual ASMs. For the cohort, 12 patients had IED observed only on the low-ASM epoch (which were not present on the high-ASM epoch), 6 of which were treated with levetiracetam. In summary, our findings showed weaning of levetiracetam was associated with a significant increase in IEDs whereas other ASMs were not. Some populations of IEDs were only seen after ASMs were weaned. These findings suggest that different ASMs may have unique effects on IEDs when weaned.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.